selectabio.com Open in urlscan Pro
104.198.7.103  Public Scan

Submitted URL: http://selectabio.com/
Effective URL: https://selectabio.com/
Submission: On October 17 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

Skip to content

Selecta Biosciences

Primary Menu
 * Platform
 * Portfolioopen/close
   * Overview
   * Pipeline
   * Autoimmune
   * Gene Therapy
   * Biologic Therapy
 * Partnerships
 * Resources
 * About Usopen/close
   * Overview
   * Leadership
   * Board of Directors
 * Careers
 * Investors & Media


OUR MISSION


PIONEERING PRECISION IMMUNE TOLERANCE

Aiming to restore natural immune system balance by re-imagining immunotherapy
for autoimmune disease, unlocking the potential of gene therapy and amplifying
the efficacy of biologic therapy.

Discover How


OUR PURPOSE

Selecta Biosciences is a clinical stage biotechnology company with a commitment
to solving the challenges associated with autoimmunity and unwanted
immunogenicity through our pioneering ImmTOR® precision immune tolerance
platform.

OUR PLATFORM


IMMTOR® PRECISION IMMUNE TOLERANCE PLATFORM

We believe our clinically validated ImmTOR® platform has broad applicability and
allows us to develop antigen-specific tolerogenic therapies that may selectively
mitigate unwanted immune responses. When ImmTOR® is combined with an engineered,
Treg selective IL-2 to make ImmTOR-IL™, the magnitude and durability of
antigen-specific immune tolerance may be further amplified. We are investigating
the potential of ImmTOR® and ImmTOR-IL™ in overcoming autoimmunity and unwanted
immunogenicity.

Discover the Possibilities



PORTFOLIO

LEVERAGING OUR IMMTOR®/IMMTOR-IL™ PLATFORM ACROSS AUTOIMMUNE DISEASE, GENE
THERAPY AND BIOLOGIC THERAPY

The potentially broad applicability of ImmTOR® and ImmTOR-IL™ gives us the
opportunity to restore natural immune system balance by re-imagining
immunotherapy for autoimmune disease, unlocking the potential of gene therapy
and amplifying the efficacy of biologic therapy.

Learn MORE ABOUT OUR THERAPIES

ABOUT US


DEVELOPING PRECISION IMMUNE TOLERANCE THERAPIES

We are an experienced and diverse team of scientists, physicians, and biotech
experts all working toward restoring natural immune system balance by
re-imagining immunotherapy for autoimmune disease, unlocking the potential of
gene therapy and amplifying the efficacy of biologic therapy.

Get to Know Us



JOIN OUR TEAM

Selecta is at the cutting edge of precision immune tolerance. ImmTOR® and
ImmTOR-IL™ have the potential to transform the treatment of autoimmune disease,
gene therapy paradigms and biologic therapy.

Careers at Selecta

Selecta Biosciences

 * Home
 * Platform
 * Portfolio
 * Partnerships
 * Resources
 * About Us

 * Careers
 * Investors & Media
 * Corporate Presentation
 * Contact

TwitterLinkedin
 * Terms of Use
 * Privacy Policy

© 2022 Selecta Biosciences All Rights Reserved Credits Team Portraits, Candid In
Situ Photography, and Video by David Shopper Photography, Boston